C12N 2750/14144
Chimeric viral vector comprising heterologous viral elements for production of another viral
Official title: Chimeric viral vector comprising heterologous viral elements for production of another viral vector
C12N2750/14144 (Chimeric viral vector comprising heterologous viral elements for production of another viral) appears on 17 US grants and 41 published applications in this corpus.
Search patents in C12N- Granted patents
- 17
- Published applications
- 41
- Assignees
- 26
- Inventors
- 113
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 4 |
| 2019 | 0 | 0 |
| 2020 | 1 | 4 |
| 2021 | 0 | 3 |
| 2022 | 1 | 5 |
| 2023 | 4 | 6 |
| 2024 | 2 | 9 |
| 2025 | 5 | 4 |
| 2026 | 1 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Methods of manufacturing CAR-T cells1 Sep 2026US 12,723,268 B2Crispr Therapeutics AG
- Expression cassette containing overlapping open reading frames and application16 Sep 2025US 12,416,019 B2Genevoyager (Wuhan) Co., Ltd.
- Phagemid vector17 Jun 2025US 12,331,308 B2Imperial College Innovations Limited
- Compositions and methods for treating non-age-associated hearing impairment in a human subject20 May 2025US 12,305,191 B2Akouos, Inc.
- Treatment for restoring ureagenesis in carbamoyl phosphate synthetase 1 deficiency22 Apr 2025US 12,281,323 B2The Regents of the University of California
- Adenoviral helper plasmid16 Jul 2026US 2026/0201418 A1Forge Biologics, Inc.
- Raav production in insect cells16 Apr 2026US 2026/0103729 A1Adverum Biotechnologies, Inc.
- Methods of treating non-syndromic sensorineural hearing loss1 Jan 2026US 2026/0000787 A1Akouos, Inc.
- Aav vectors for gene editing27 Nov 2025US 2025/0361525 A1Scribe Therapeutics Inc.
- Compositions and methods for treating non-age-associated hearing impairment in a human subject9 Oct 2025US 2025/0313856 A1Akouos, Inc.
Most cited
By later US patents
- Chimeric vectors35US 9,012,224 B2The University of North Carolina at Chapel Hill · 2015
- Chimeric vectors33US 7,892,809 B2The University of North Carolina at Chapel Hill · 2011
- Compositions and methods for treating non-age-associated hearing impairment in a human subject10US 11,807,867 B2Akouos, Inc. · 2023
- Chimeric adeno-associated virus/ bocavirus parvovirus vector9US 10,793,835 B2University of Iowa Research Foundation · 2020
- Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems9US 11,660,353 B2Decibel Therapeutics, Inc. · 2023